Candesartan clinical trials
Also written Blopress.
Includes 39 studies of Candesartan cilexetil.
How each study uses candesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the candesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 4 Jun 1998 · ATACAND · NDA 020838 (FDA, Drugs@FDA; as candesartan cilexetil)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
100 studies that test it; most in 2006 (11)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 3 |
| 2000 | 1 |
| 2001 | 5 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 8 |
| 2006 | 11 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 50 · Other 54
AstraZeneca (17) · Chong Kun Dang Pharmaceutical (7) · Takeda (4) · HK inno.N Corporation (3) · GlaxoSmithKline (3) · Emory University (2) · Baylor College of Medicine (2) · Mayo Clinic (2)
Often tested with
Tested in the same studies.
Amlodipine (9) · Ramipril (7) · Hydrochlorothiazide (6) · Lisinopril (5) · Valsartan (4) · Enalapril (4) · Chlorthalidone (3) · Rosuvastatin (3)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses candesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 104
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as AtacandHow we know
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryEnrolling by invitationPhase 2University of California, San FranciscoNCT05826912Written as Candesartan CilexetilHow we know
- To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaEnrolling by invitationPhase 3Hyundai PharmNCT06646354Written as Ezetimibe/Rosuvastatin/Candesartan/AmlodipineHow we know
- Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)RecruitingPhase 3Cristina Avendaño SoláNCT05321875Written as CandesartanHow we know
- Effect of Some Drugs on Liver FibrosisRecruitingPhase 3Sherief Abd-ElsalamNCT03770936Written as CandesartanHow we know
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedPhase 1Tanabe Pharma CorporationNCT01976572Written as candesartanHow we know
- Candesartan for Migraine Prevention:CompletedPhase 2St. Olavs HospitalNCT04574713Written as Candesartan Oral Tablet 8 mgHow we know
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionCompletedPhase 3Hospital Israelita Albert EinsteinNCT05920005Written as candesartan cilexetil + chlorthalidone + amlodipineHow we know
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedPhase 1HanAll BioPharma Co., Ltd.NCT02988362Written as Candesartan 16mg and Amlodipine 10mgHow we know
- Adiposity and Endothelin Receptor FunctionActive, not recruitingEarly Phase 1Augusta UniversityNCT03583866Written as CandesartanHow we know
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19TerminatedPhase 2University of SydneyNCT05122182Written as Candesartan CilexetilHow we know
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedPhase 3HK inno.N CorporationNCT02368652Written as Candesartan cilexetil 16mgHow we know
- Candesartan's Effects on Alzheimer's Disease And Related BiomarkersCompletedPhase 2Emory UniversityNCT02646982Written as CandesartanHow we know
- Candesartan as an Adjunctive Treatment for Bipolar DepressionWithdrawnEarly Phase 1The University of Texas Health Science Center, HoustonNCT04430959Written as CandesartanHow we know
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedPhase 1Baylor College of MedicineNCT01062451Written as CandesartanHow we know
- CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral FunctionCompletedPhase 1/2Mayo ClinicNCT01678794Written as CandesartanHow we know
- Candesartan in Peripheral NeuropathyTerminatedPhase 2University Hospital, LimogesNCT03688633Written as CandesartanHow we know
- The Precision Hypertension Care StudyCompletedPhase 4Uppsala UniversityNCT02774460Written as Atacand®How we know
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)Status unknownPhase 2/3Medical University of ViennaNCT04351724Written as CandesartanHow we know
- CAndesartan vs LIsinopril Effects on the BRainCompletedPhase 2Emory UniversityNCT01984164Written as CandesartanHow we know
See all 104 studies that test candesartan →
Given beside what is tested · 10 — candesartan is usual care or a partner of the new treatment
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as CandesartanHow we know
- Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedPhase 3Chong Kun Dang PharmaceuticalNCT02651870Written as Candesartan 16mgHow we know
- Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)CompletedPhase 1Merck Sharp & Dohme LLCNCT01025843Written as Comparator: Candesartan cilexetilHow we know
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedPhase 4Institut für Pharmakologie und Präventive MedizinNCT01611077Written as Candesartan cilexetilHow we know
- DP-R208 Pharmacokinetic StudyCompletedPhase 1Alvogen KoreaNCT02709187Written as Candesartan cilexetilHow we know
- Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineCompletedPhase 3Institut für Pharmakologie und Präventive MedizinNCT01613209Written as Candesartan cilexetilHow we know
- Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male SubjectsStatus unknownPhase 1Ahn-Gook Pharmaceuticals Co.,LtdNCT02614352Written as Atorvastatin + CandesartanHow we know
- Bioequivalence Study of CJ-30059Status unknownPhase 1HK inno.N CorporationNCT02173912Written as Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference)How we know
- Candesartan Effect in Second Stage Arterial HypertensionCompletedPhase 4AstraZenecaNCT00621153Written as Candesartan CilexetilHow we know
- CCB Safety Study in Treatment of Hypertension of ADPKDStatus unknownPhase 4Kyorin UniversityNCT00541853Written as CandesartanHow we know
As the comparator · 17 — what is tested is compared with candesartan
- SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive TherapyNot yet recruitingPhase 4Ottawa Hospital Research InstituteNCT07687160Written as Candesartan 8mgHow we know
- Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)Not yet recruitingPhase 4Stanford UniversityNCT07655440Written as CandesartanHow we know
- Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for HypertensionCompletedPhase 2Washington University School of MedicineNCT03640312Written as CandesartanHow we know
- Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionCompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT06212648Written as SPC3001How we know
- Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCompletedPhase 4HK inno.N CorporationNCT03847506Written as Candesartan cilexetil/Amlodipine besylateHow we know
- A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedPhase 4Chong Kun Dang PharmaceuticalNCT04521023Written as Candemore Plus TabHow we know
- A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCompletedPhase 2TakedaNCT02332824Written as Candesartan cilexetilHow we know
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWithdrawnPhase 3BayerNCT02047019Written as Candesartan CilexetilHow we know
- Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each MonotherapyCompletedPhase 3Alvogen KoreaNCT02770261Written as Candesartan32mgHow we know
- Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting ConditionsCompletedPhase 1BayerNCT01227603Written as Candesartan (Atacand)How we know
- Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02548286Written as Candesartan 8mgHow we know
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic LesionsCompletedPhase 3Baim Institute for Clinical ResearchNCT00081731Written as Atacand/HCT, CaduetHow we know
- Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNot applicableKyoto Prefectural University of MedicineNCT00863980Written as Blopress (Candesartan)How we know
- Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy VolunteersCompletedPhase 4Boehringer IngelheimNCT02261116Written as CandesartanHow we know
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedPhase 2TakedaNCT01289132Written as Candesartan cilexetilHow we know
- Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate HypertensionStatus unknownPhase 3University of PaviaNCT00644475Written as CandesartanHow we know
- CCB Safety Study in Treatment of Hypertension of ADPKDStatus unknownPhase 4Kyorin UniversityNCT00541853Written as CandesartanHow we know
Codes
What other systems call candesartan · ClinicalTrials.gg INT003731
- MeSH (NLM) C081643candesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S8Q36MD2XXCANDESARTANConfirmed FDA, NLM, Wikidata
- RxNorm 214354Confirmed FDA, Wikidata
- Wikidata Q415970candesartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65284CandesartanOne source FDA
- DrugBank DB13919One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C081643 | candesartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S8Q36MD2XX | CANDESARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 214354 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415970 | candesartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65284 | Candesartan | One source FDA |
| DrugBank | DB13919 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.